These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12359367

  • 1. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.
    Zajc I, Sever N, Bervar A, Lah TT.
    Cancer Lett; 2002 Dec 10; 187(1-2):185-90. PubMed ID: 12359367
    [Abstract] [Full Text] [Related]

  • 2. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.
    Levicar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, Lah TT.
    Cancer Detect Prev; 2002 Dec 10; 26(1):42-9. PubMed ID: 12088202
    [Abstract] [Full Text] [Related]

  • 3. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
    Colella R, Casey SF.
    Biotech Histochem; 2003 Apr 10; 78(2):101-8. PubMed ID: 14533846
    [Abstract] [Full Text] [Related]

  • 4. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
    Trinkaus M, Vranic A, Dolenc VV, Lah TT.
    Int J Biol Markers; 2005 Apr 10; 20(1):50-9. PubMed ID: 15832773
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
    Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, Rudolf Z, Zargi M, Krasovec M, Svetic B, Kopitar-Jerala N, Kos J.
    Biol Chem Hoppe Seyler; 1996 Jun 10; 377(6):385-90. PubMed ID: 8839984
    [Abstract] [Full Text] [Related]

  • 6. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases.
    Lenarcic B, Krizaj I, Zunec P, Turk V.
    FEBS Lett; 1996 Oct 21; 395(2-3):113-8. PubMed ID: 8898076
    [Abstract] [Full Text] [Related]

  • 7. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
    Premzl A, Puizdar V, Zavasnik-Bergant V, Kopitar-Jerala N, Lah TT, Katunuma N, Sloane BF, Turk V, Kos J.
    Biol Chem; 2001 May 21; 382(5):853-7. PubMed ID: 11517941
    [Abstract] [Full Text] [Related]

  • 8. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
    Bervar A, Zajc I, Sever N, Katunuma N, Sloane BF, Lah TT.
    Biol Chem; 2003 Mar 21; 384(3):447-55. PubMed ID: 12715895
    [Abstract] [Full Text] [Related]

  • 9. Cystatins and cathepsins in breast carcinoma.
    Lah TT, Kokalj-Kunovar M, Drobnic-Kosorok M, Babnik J, Golouh R, Vrhovec I, Turk V.
    Biol Chem Hoppe Seyler; 1992 Jul 21; 373(7):595-604. PubMed ID: 1515089
    [Abstract] [Full Text] [Related]

  • 10. Cysteine cathepsins B and L and their inhibitors stefins A and B in carcinoma of the oropharynx: immunohistochemical study.
    Strojan P, Oblak I, Gale N, Smid L, Kos J.
    Histopathology; 2008 Nov 21; 53(5):612-4. PubMed ID: 18983473
    [No Abstract] [Full Text] [Related]

  • 11. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL.
    J Pathol; 2008 Feb 21; 214(3):337-46. PubMed ID: 17985332
    [Abstract] [Full Text] [Related]

  • 12. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia.
    Altiok O, Yasumatsu R, Bingol-Karakoc G, Riese RJ, Stahlman MT, Dwyer W, Pierce RA, Bromme D, Weber E, Cataltepe S.
    Am J Respir Crit Care Med; 2006 Feb 01; 173(3):318-26. PubMed ID: 16166622
    [Abstract] [Full Text] [Related]

  • 13. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E, Procházka J, Kárová B, Cermák J, Roubková H.
    Neoplasma; 1998 Feb 01; 45(5):318-31. PubMed ID: 9921922
    [Abstract] [Full Text] [Related]

  • 14. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma.
    Lah TT, Kokalj-Kunovar M, Strukelj B, Pungercar J, Barlic-Maganja D, Drobnic-Kosorok M, Kastelic L, Babnik J, Golouh R, Turk V.
    Int J Cancer; 1992 Jan 02; 50(1):36-44. PubMed ID: 1728611
    [Abstract] [Full Text] [Related]

  • 15. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing.
    Dahl SW, Halkier T, Lauritzen C, Dolenc I, Pedersen J, Turk V, Turk B.
    Biochemistry; 2001 Feb 13; 40(6):1671-8. PubMed ID: 11327826
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of bovine cathepsins L and S by stefins and cystatins.
    Leonardi A, Turk B, Turk V.
    Biol Chem Hoppe Seyler; 1996 May 13; 377(5):319-21. PubMed ID: 8828823
    [Abstract] [Full Text] [Related]

  • 17. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT, Nanni I, Trinkaus M, Metellus P, Dussert C, De Ridder L, Rajcević U, Blejec A, Martin PM.
    J Neurosurg; 2010 May 13; 112(5):940-50. PubMed ID: 19747051
    [Abstract] [Full Text] [Related]

  • 18. Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines.
    Colella R, Goodwyn E, Gopal P.
    Cancer Lett; 2002 Nov 28; 185(2):163-72. PubMed ID: 12169390
    [Abstract] [Full Text] [Related]

  • 19. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
    Turk V, Brzin J, Kotnik M, Lenarcic B, Popović T, Ritonja A, Trstenjak M, Begić-Odobasić L, Machleidt W.
    Biomed Biochim Acta; 1986 Nov 28; 45(11-12):1375-84. PubMed ID: 3495261
    [Abstract] [Full Text] [Related]

  • 20. Contributions of individual residues in the N-terminal region of cystatin B (stefin B) to inhibition of cysteine proteinases.
    Pol E, Björk I.
    Biochim Biophys Acta; 2003 Jan 31; 1645(1):105-12. PubMed ID: 12535617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.